Hide Board Information

Show Board Information

Lexington Biosciences Inc LXGTF

Board Mod: Roger Wilco

Asst Mods:

Last Post: 02/18/2018 2:01:24 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Lexington Biosciences Inc (OTCMRKTS: LXGTF) Stock Message Board

1. LXGTF Company Profile

    

2. LXGTF Time & Sales

    

3. LXGTF Recent News

    

4. LXGTF Filings

    

5. LXGTF Financials

    

6. LXGTF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

5	https://www.bullishhorns.com/single-post/2017/10/	jimbosskow	02/18/2018 2:01:24 PM
4	https://globenewswire.com/news-release/2018/02/13	jimbosskow	02/17/2018 7:43:33 AM
3	Stock Chart on LXGTF (1)	Roger Wilco	10/22/2017 2:34:17 PM
2	OTCQB just started trading this year (1)	Roger Wilco	10/22/2017 2:32:57 PM
1	Lexington BioSciences (CSE: LNB) (OTC: LXGTF), (1)	Roger Wilco	10/22/2017 2:28:22 PM

Recent Articles

• Celebrating Cinema at the 20th China Film Huabiao Awards
• Movado Group Faces SEC Scrutiny, Rosen Law Firm Steps In
• Experience the Thrill of Japan Open Poker Tour 2025
• A.I.S. Resources Completes Successful Private Placement Initiative
• Ready Capital Shareholder Legal Updates: Know Your Rights
• Investors Urged to Act: Lawsuits Filed Against e.l.f. Beauty
• Understanding Your Rights as a Bancorp Investor in Legal Matters
• Important Update for Viatris Investors: Legal Action Insights
• AppLovin Investors Reminded of Important Class Action Deadline
• Investors Have a Deadline to Join NET Power Class Action
• Fluence Energy Class Action Update: Important Deadline Approaches
• AppLovin Corporation Faces Shareholder Class Action Opportunities
• Formosa Pharmaceuticals Partners With Saval For New Eye Treatment
• Antengene Showcases Innovative Therapeutics at AACR Event
• 51Talk Online Education Group Releases Key Annual Report for 2024
• Skye Bioscience Unveils Stock Option Grant for New Employee
• Innovent Celebrates NMPA Approval of Limertinib for Lung Cancer Treatment
• Willow Biosciences Reveals Results from Recent Shareholder Meeting
• Investigation into Bitfarms Ltd: What Investors Should Know
• Investigation into HealthEquity, Inc. Sparks Investor Interest
• Creative Science Expands Horizons with Astaria Global Acquisition
• Investors Encouraged to Join Canopy Growth Class Action Suit
• Rosen Law Firm Initiates Investigation for Bitfarms Investors
• Agnico Eagle's 2025 Shareholder Meeting: Directors Elected
• Orbia's Exciting Offer: Tender for Senior Notes Unveiled
• Concord Medical Submits Annual Report for Fiscal Year 2024
• BankFirst Capital Corporation Posts Strong Q1 Performance
• Espire Dental Unifies Workforce at Engaging Conference Event
• Aliya Health Group Welcomes New Leaders to Enhance Care
• 17 Education & Technology Group Inc. Releases Annual Financial Report
• Kellanova Board Approves New $0.57 Dividend for Shareholders
• Exploring Christian Zionism: New Podcast Series Launches
• Graze Robotics and Invited Launch Pioneering Mowing Initiative
• Medtronic's OmniaSecure Lead Revolutionizes Cardiac Care Innovations
• Celebrate Planning with Plum Paper's Customer Appreciation Sale
• Innovative Grant Initiative to Foster Community Health Equity
• Investigating the HarborOne Bancorp and Eastern Bankshares Deal
• Celularity Faces Delisting Notice From Nasdaq Over Fees
• Paul Mueller Company Q1 Earnings Show Significant Growth
• Trillion Energy Takes Major Steps to Restructure Debt Efficiently
• Credicorp Ltd. Files Annual Report Showcasing Growth Insights
• Wheels Up's Commitment to Strategic Growth Amid NYSE Notice
• Fairfax Financial Holdings to Host Conference Call for Q1 Results
• AGF Investments Reveals New Final Distribution for ETF Holders
• Lug's Commitment to Sensory Accessibility with KultureCity Partnership
• Cadence Bank and Industry Bancshares Join Forces in Merger
• Zepp Health Corporation Announces Filing of 2024 Annual Report
• Innovative Neuro-Oncology Solutions with Dr. Neil A. Martin
• Integral Metals Enhances Marketing Strategy with Extension Plans
• NIP Group Set to Unveil Financial Performance Soon